OrthoXel is a growing, dynamic, young company working specifically in the field of orthopaedic trauma, currently highly focused on intramedullary nailing systems. The first device that OrthoXel has worked on is the Apex Tibial Nailing System. The nailing system has recently been FDA 510(K) and CE Mark cleared, for commercialisation in the US and European markets respectively. Click here for the full Press Release.
The basic R&D and proof of principle for the Apex Tibial Nailing System was completed in OrthoXel’s home city of Cork, at the Cork Institute of Technology‘s MEDIC Centre, over a five year development process. This work included iterative design-build-test activities, bench testing, cadaver studies, and GLP-controlled pre-clinical study.
OrthoXel is excited to announce that European Clinical trials for the Apex Tibial Nailing System are now underway, and so far all indications seem positive. Click here to read the full Press Release on the world’s first patient implantation of the Apex Tibial Nailing System, performed by Professor James Harty, Consultant Orthopaedic Surgeon and Head of the Department for Orthopaedics at Cork University Hospital.